Skip to content
TheChatArchiveThe Chat Archive
Grok 4.1 Fast· xaiHugging Face Frontier Reasoning Traces

Launch an inpatient hyponatremia playbook: classification, safe correction rules,…

  1. User

    Launch an inpatient hyponatremia playbook: classification, safe correction rules, monitoring ladders, and relapse prevention.

  2. Assistant

    Inpatient Hyponatremia Playbook

    Sherlock AI Protocol | Trailblazer Labs
    Rapid reference for inpatient management. Confirm diagnosis (Na⁺ <135 mEq/L). Assess symptoms (none/mild: headache, N/V; severe: seizures, coma). Always evaluate acuity (acute <48h vs. chronic >48h) and volume status first. Consult nephrology/endocrinology early.

    1. Classification

    Classify by severity, acuity, and volume status to guide therapy.

    SeverityNa⁺ (mEq/L)Symptoms
    Mild130–134Asymptomatic or mild (fatigue, N/V)
    Moderate125–129Moderate (headache, confusion)
    Severe<125Severe (seizures, coma, resp arrest)

    Volume Status (clinical + labs: urine Na/Osms, serum Osms):

    • Hypovolemic (10–15% cases): Dehydration (GI losses, diuretics, hemorrhage). Urine Na⁺ <20, FeNa <1%.
    • Euvolemic (75%): SIADH, hypothyroidism, adrenal insuff. Urine Osms >100, urine Na⁺ >40.
    • Hypervolemic (15%): CHF, cirrhosis, nephrotic. Edema, low effective volume.

    Etiology Ladder (common inpatient):

    1. SIADH (drugs: SSRI, carbamazepine; pulmonary/CNS disease)
    2. Hypervolemic (heart/liver/kidney failure)
    3. Hypovolemic (GI/renal losses)
    4. Pseudohyponatremia (hyperlipidemia/hyperglycemia)
    5. Other: Beer potomania, exercise, MDMA

    2. Safe Correction Rules

    Core Principle: Prevent osmotic demyelination (ODS). Limit ΔNa⁺:

    • Acute symptomatic: 4–6 mEq/L in 4–6h.
    • Chronic/asymptomatic: <8 mEq/L in 24h; <18 mEq/L in 48h.
    • High-risk ODS (malnourished, alcoholics, hypokalemia): <6 mEq/L/24h.
    • Stop/reverse if overcorrection (>10 mEq/L/24h): D5W 6 mL/kg bolus + desmopressin 2–4 mcg IV.

    Therapy Ladder (titrate based on class/symptoms):

    ScenarioInitial TherapyDose/RateTarget ΔNa⁺
    Severe symptoms (seizure/coma) All types3% saline IV bolus100–150 mL over 10–20 min (2–3 mL/kg); repeat ×2 if needed+4–6 mEq/L in 1–4h
    Moderate symptoms3% saline infusion1–2 mL/kg/h ×4–6h+4–6 mEq/L in 6h
    Mild/asymptomatic hypovolemicIsotonic saline (0.9% NS)1–2 L bolus, then maintenanceMatch losses
    Mild/asymptomatic euvolemic/hypervolemicFluid restriction800–1000 mL/day<0.5 mEq/L/h
    Refractory SIADHTolvaptan (Vasostrict) or urea15 mg PO BID; taper<8/24h
    Hyperacute (<24h)Hypertonic saline + loop diuretic3% saline + furosemide 20–40 mg IV+6–8 mEq/L/24h OK

    Formulas:

    • Infusion rate (3% saline): (Target ΔNa × TBW × 0.6) / 1 (for 513 mEq/L saline). TBW = 0.6 × wt (men), 0.5 × wt (women).
    • Adrogue-Madias: Change = [Infusate Na – Serum Na] / (TBW +1).

    3. Monitoring Ladders

    q1–2h initially → step down based on stability. Neuro checks q4h.

    PhaseLabs (Na⁺, K⁺, Osms)Vitals/ClinicalDuration
    Acute Phase (symptomatic, 3% saline)q1–2h ×6h, then q4–6hNeuro q1h, I/Os strict, daily wtUntil stable
    Stabilization (ΔNa <6 mEq/L)q6–8h ×24h, then q12hNeuro q4h, I/Os24–48h
    Maintenance (asymptomatic)q12–24hNeuro q shift, I/Os permissiveUntil discharge
    High-Risk (chronic + risk factors)q4h ×48hDaily neuro exam48h min
    • Red Flags: ΔNa >8/24h → hold therapy, D5W bolus.
    • Telemetry if arrhythmia risk (hypoK common).

    4. Relapse Prevention

    80% relapse risk without intervention. Discharge planning:

    StrategyIndicationsDetails
    Treat CauseAllStop inciting drugs (thiazides, SSRIs); Rx hypothyroidism/adrenal insuff.
    Fluid RestrictionSIADH/euvolemic1–1.5 L/day lifelong; educate pt/family.
    Salt Tab + Loop DiureticSIADH relapseNaCl 3–6g/day + furosemide 20 mg/d.
    VaptansRefractory SIADHTolvaptan 15–30 mg/d; monitor LFTs, Na q24h.
    UreaMild SIADH15–30g PO BID; cheap, safe alt.
    HypervolemicCHF/cirrhosisOptimize GDMT (diuretics, ACEi); salt/fluid restrict.

    Discharge Criteria:

    • Na stable >130 ×24h.
    • Asymptomatic.
    • Etiology addressed.
    • F/U plan: Nephro/endo in 1–2wk; home Na check if high-risk.

    Evidence Base: Derived from US/EU expert consensus (2013–2023): Spasovski, Verbalis, Sterns. Tailor to pt; this is not personalized medical advice—verify with EMR/chart.

    Playbook launched. Query for case-specific tweaks?

Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.